The Bad News Heading Into AbbVie’s First-Quarter Earnings Report
Investor's Business DailyAbbVie stock has slumped 9% off its record high in March and is facing increasingly steep competition for its biggest moneymaker, Humira.
The post The Bad News Heading Into AbbVie's First-Quarter Earnings Report appeared first on Investor's B…